UBE2S and neoplasm: Compared with conventional strategies, small-molecule inhibitors are more acceptable in the treatment of tumors including HCC, owing to their low cost, specificity and ease of administration.41,42 By screening a variety of compounds, we discovered that cephalomannine could significantly inhibit the expression of UBE2S and attenuate cell growth in various HCC lines and tumor growth in vivo.